EFS
TGTX icon

Essex Financial Services’s TG Therapeutics TGTX Stock Holding History

Essex Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+3,748
New +$153K 0.01% 796

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Essex Financial Services's TGTX Position: Q2 2026 in Review

Essex Financial Services opened a new position in TG Therapeutics (TGTX) in Q2 2026: 3,748 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #796 among its holdings.

284 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Essex Financial Services held 3,748 shares of TG Therapeutics worth $206K as of Q2 2026.
  • TG Therapeutics was a new Essex Financial Services position in Q2 2026.
  • TG Therapeutics made up 0.01% of Essex Financial Services's portfolio in Q2 2026, its #796 holding.
  • 284 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.